+8615710194249

News Center

Marcin Bugno

2024-03-13

Dr. Marcin Bugno is the Vice President, Head of RNA Development. He has 20 years of R&D experience in academia, biotech and large pharma companies. Prior to joining Immorna, Dr. Bugno served as Senior Director, Analytical and Process Development at Istari Oncology, Director of Technical R&D, Drug Substance at GSK Vaccines and manager of process development and tech transfer teams at Novartis Vaccines and Diagnostics. He has experience in analytical and process development for recombinant viral products, protein biologics, and mRNA vaccines; including RNA drug substance process development and manufacturing support for the first-in-human GSK RNA vaccine program as well as cell line and process development for GSK’s Arexvy, the licensed respiratory syncytial virus (RSV) vaccine. Dr. Bugno published 18 research papers and 3 patents in the field of process science, cell biology, virology, biochemistry and molecular biology.